The DOI matches its Crossref record.
STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN*
Open accessAbstract
Link (1) suggested in 1948 that the coumarin compound warfarin be used as a rodenticide.Its first human use was in a suicide attempt in 1952 (2).Although warfarin has been employed in- creasingly in the treatment of thromboembolic disorders (3-5), no published reports of its physi- ologic disposition in man have appeared, probably owing largely to the lack of a suitable method for its measurement in biologic fluids (6).Weiner, Brodie, and Burns (7, 8) stated that the half-life of warfarin in man is 90 hours, but did not include the assay method, or give supporting data.In 1953, Yuyama, Goto, and Umezu (9) described a colorimetric method for the estimation of warfarin in rat plasma, but apparently this method was never applied to man.Since 1954, several investigations of warfarin in the rat have appeared, including the studies of Garner (10), Eble (11), and Lin (12).Their methods, how- ever, were unpublished except as doctoral theses, or were not readily adaptable for studies in man.Recently, we described a spectrophotometric method for the estimation of warfarin in biologic fluids (13), and have used this method in the present study to investigate the pharmiacodynamics of warfarin in man.We determined the concentrations of warfarin in the plasma and of a warfarin metabolite in the urine of normal subjects after both oral and intravenous adminis- tration of the drug.Analysis of the data provided information on its absorption, elimination, ap- parent volume of distribution, and excretion.Differences in its biologic effect were evaluated by simultaneous measurements of its plasma con- centration and of prothrombin complex activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics
Nguyen, T. H. T., Mouksassi, M., Holford, N., Al‐Huniti, N., Freedman, I., Hooker, A. C., John, J., Karlsson, M. O., Mould, D. R., Pérez Ruixo, J. J., et al. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12161 · Cited by 402
Holford, N. H. G. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611060-00005 · Cited by 360
de la Peña, A., Cui, X., Geiser, J., & Loghin, C. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0531-7 · Cited by 31
PharmML in Action: an Interoperable Language for Modeling and Simulation
Bizzotto, R., Comets, E., Smith, G., Yvon, F., Kristensen, N., & Swat, M. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12213 · Cited by 9
Metadata
- Authors
- O'Reilly, R. A., Aggeler, P. M., & Leong, L. S.
- Venue
- Journal of Clinical Investigation
- Published
- 1963-10-01
- Volume
- 42
- Issue
- 10
- Pages
- 1542-1551
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2029064284
- Cited by
- 209
- References
- 0
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN*. https://app.cochat.ai/papers/10.1172/jci104839
- The paper
- O'Reilly, R. A., Aggeler, P. M., & Leong, L. S. (1963). STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN*. Journal of Clinical Investigation. https://doi.org/10.1172/jci104839
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.